Judge overseeing all Suboxone tooth decay lawsuits brought in the federal court system heard oral arguments this week, and is considering whether the claims should be preempted by federal law.
Lawsuits allege that recalled BioZorb Markers failed to absorb into the body after breast cancer treatments, resulting in painful complications and the need for additional medical procedures.
